Tasly Pharmaceutical Group Co., Ltd

This study tested a new drug called STRO-002 in 19 Chinese adults with advanced ovarian, endometrial, or other solid tumors that had not responded to prior treatments. STRO-002 is an antibody-drug conjugate, meaning it combines a targeted antibody with a chemotherapy drug to deli…

This Phase 3 trial tested whether Qingzhu Granules, a traditional Chinese herbal medicine, can reduce pain from acute gouty arthritis. 472 adults with a gout flare took either the granules or a placebo for 72 hours. The main goal was to see if pain scores improved more with the r…

This study tested whether the drug pimavanserin can safely reduce hallucinations and delusions in people with Parkinson's disease psychosis. 248 participants took either the drug or a placebo daily for 6 weeks. The main goal was to see if symptoms improved, measured by a standard…

This phase 2 trial tested whether a new drug called JS1-1-01 can safely reduce symptoms in 267 adults with moderate to severe depression. Participants took either the drug or a placebo for 8 weeks. Researchers measured changes in depression scores to see if the drug helps.